Scarica l'app Stockscreener
2.80
2.19%
0.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$2.74
Aprire:
$2.74
Volume 24 ore:
1.27M
Relative Volume:
0.67
Capitalizzazione di mercato:
$216.57M
Reddito:
$10.42B
Utile/perdita netta:
$-38.77M
Rapporto P/E:
-5.4902
EPS:
-0.51
Flusso di cassa netto:
$323.54M
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
-39.52%
1 anno Prestazione:
-66.75%
Intervallo 1D:
$2.69
$2.82
Intervallo di 1 settimana:
$2.69
$2.82
Portata 52W:
$2.38
$10.43
Accendra Health Inc Stock (OMI) Company Profile
Nome
Accendra Health Inc
Settore
Industria
Telefono
(804) 723-7000
Indirizzo
10900 NUCKOLS ROAD, GLEN ALLEN, VA
Compare OMI vs MCK, COR, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMI
Accendra Health Inc
|
2.80 | 216.57M | 10.42B | -38.77M | 323.54M | -0.51 |
|
MCK
Mckesson Corporation
|
947.33 | 114.55B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
365.78 | 70.03B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
225.71 | 51.83B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
81.39 | 9.54B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.41 | 793.60M | 2.22M | -5.63M | -1.68M | -0.24 |
Accendra Health Inc Stock (OMI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Downgrade | UBS | Buy → Neutral |
| 2024-07-19 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-12 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-10-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | Ripresa | Citigroup | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-30 | Ripresa | JP Morgan | Underweight |
| 2020-12-17 | Aggiornamento | UBS | Neutral → Buy |
| 2020-09-25 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-05-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-01-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-06 | Reiterato | BofA/Merrill | Neutral |
| 2019-04-10 | Reiterato | BofA/Merrill | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-01 | Reiterato | Barclays | Underweight |
| 2018-10-31 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-03-08 | Iniziato | Barclays | Underweight |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2017-12-19 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-01 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2016-11-07 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2016-04-21 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2016-03-16 | Iniziato | Credit Suisse | Underperform |
| 2015-12-07 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Accendra Health Inc Borsa (OMI) Ultime notizie
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
AASTOCKS Financial NewsAccendra Health, Inc. (ACH) - AASTOCKS.com
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
ACH (Accendra Health) Interest Coverage : 1.94 (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) EV-to-OCF : -23.35 (As of Jan. 07, 2026) - GuruFocus
ACH (Accendra Health) Current Deferred Revenue : $0 Mil (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) ROCE % : 6.66% (As of Sep. 2025) - GuruFocus
Return on assets % of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView — Track All Markets
ETFs Investing in Accendra Health, Inc. Stocks - TradingView — Track All Markets
ACH Forecast — Price Target — Prediction for 2027 - TradingView — Track All Markets
Accendra Health, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Diluted net income available to common stockholders of Accendra Health, Inc. – BOATS:ACH - TradingView — Track All Markets
Accendra Health (NYSE: OMI) adds pro forma data on P&HS sale - Stock Titan
It’s official: Accendra Health goes live on NYSE, unveils new website - HME News
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
ACH Seasonals Chart - TradingView — Track All Markets
Net current asset value per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Revenue per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc. Financial Disclosures & SEC Filings - TradingView — Track All Markets
Free cash flow per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc.: Target Price Consensus and Analysts Recommendations | 6OM | US6907321029 - MarketScreener
Accendra Health, Inc.: Revenue and Earnings Analysts Forecasts Revisions | 6OM | US6907321029 - MarketScreener
Accendra Health begins trading on NYSE under new ticker symbol By Investing.com - Investing.com Nigeria
Accendra Health Inc (NYSE: ACH)Related Research - intelligentinvestor.com.au
6OM: Static price chart | Accendra Health, Inc. | US6907321029 - MarketScreener
Platinum Equity Completes Acquisition of Owens & Minor Products & Healthcare Services Business - Platinum Equity
Owens & Minor rebrands after $375M sale of largest division - Virginia Business
Two execs exit Accendra Health as Products & Healthcare Services sale closes - HME News
ACH Stock Price Today - Stock Titan
Two new option listings and three option delistings on January 2nd - TipRanks
Owens & Minor (OMI) Options to be Delisted in Early January - GuruFocus
Platinum Equity Completes Acquisition Of Owens & Minor Products & Healthcare Services Business - Pulse 2.0
Accendra Health begins trading on NYSE under new ticker symbol - Investing.com
Accendra Health to Begin Trading on NYSE under New Ticker “ACH” - TradingView — Track All Markets
Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH” - FinancialContent
Accendra Health, Inc.: Top Mutual Funds Holders | OMI | US6907321029 - MarketScreener
Owens & Minor, Inc. will Change its Ticker to ACH from OMI - marketscreener.com
Owens & Minor completes sale of products segment, rebrands as Accendra By Investing.com - Investing.com India
Owens & Minor completes sale, transforms to Accendra Health - MSN
Owens & Minor completes sale of products segment, rebrands as Accendra - Investing.com Nigeria
Owens & Minor completes sale of products & healthcare services business to Platinum Equity - MarketScreener
Accendra Health Inc Azioni (OMI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Accendra Health Inc Azioni (OMI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
| Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 09 '25 |
Buy |
7.39 |
225,000 |
1,662,750 |
11,482,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 08 '25 |
Buy |
7.96 |
105,000 |
835,800 |
11,257,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 10 '25 |
Buy |
7.19 |
80,000 |
575,200 |
11,562,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 07 '25 |
Buy |
7.84 |
240,000 |
1,881,600 |
11,152,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 03 '25 |
Buy |
8.53 |
160,000 |
1,364,800 |
10,784,599 |
| Coliseum Capital Management, L | 10% Owner |
Apr 04 '25 |
Buy |
8.14 |
128,356 |
1,044,818 |
10,912,955 |
| Coliseum Capital Management, L | 10% Owner |
Feb 28 '25 |
Buy |
9.39 |
1,738,511 |
16,324,618 |
9,469,698 |
| Coliseum Capital Management, L | 10% Owner |
Mar 04 '25 |
Buy |
9.75 |
800,000 |
7,800,000 |
10,624,599 |
8.70%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):